159 related articles for article (PubMed ID: 38250609)
1. How to Defeat Multidrug-Resistant Bacteria in Intensive Care Units. A Lesson from the COVID-19 Pandemic. Prevention, Reservoirs, and Implications for Clinical Practice.
Woźniak A; Janc J; Łysenko L; Leśnik P; Słabisz N; Oleksy-Wawrzyniak M; Uchmanowicz I
Int J Med Sci; 2024; 21(3):530-539. PubMed ID: 38250609
[No Abstract] [Full Text] [Related]
2. Characteristics of Microbial Factors of Healthcare-Associated Infections Including Multidrug-Resistant Pathogens and Antibiotic Consumption at the University Intensive Care Unit in Poland in the Years 2011-2018.
Litwin A; Fedorowicz O; Duszynska W
Int J Environ Res Public Health; 2020 Sep; 17(19):. PubMed ID: 32977435
[No Abstract] [Full Text] [Related]
3. Impact of the COVID-19 pandemic on the incidence of multidrug-resistant bacterial infections in an acute care hospital in Brazil.
Polly M; de Almeida BL; Lennon RP; Cortês MF; Costa SF; Guimarães T
Am J Infect Control; 2022 Jan; 50(1):32-38. PubMed ID: 34562526
[TBL] [Abstract][Full Text] [Related]
4. Multidrug-resistant OXA-48/CTX-M-15 Klebsiella pneumoniae cluster in a COVID-19 intensive care unit: salient lessons for infection prevention and control during the COVID-19 pandemic.
Howard-Jones AR; Sandaradura I; Robinson R; Orde SR; Iredell J; Ginn A; van Hal S; Branley J
J Hosp Infect; 2022 Aug; 126():64-69. PubMed ID: 35562071
[TBL] [Abstract][Full Text] [Related]
5. Multidrug-Resistant Bacterial Colonization and Infections in Large Retrospective Cohort of Mechanically Ventilated COVID-19 Patients
Mangioni D; Chatenoud L; Colombo J; Palomba E; Guerrero FA; Bolis M; Bottino N; Breda G; Chiaruttini MV; Fior G; Marotta M; Massobrio G; Matinato C; Muscatello A; Previtali P; Santambrogio S; Tardini F; Zuglian G; Grasselli G; Fumagalli R; Gori A; Stocchetti N; Monti G; Bandera A;
Emerg Infect Dis; 2023 Aug; 29(8):1598-1607. PubMed ID: 37486196
[TBL] [Abstract][Full Text] [Related]
6. Protective effect of SARS-CoV-2 preventive measures against ESKAPE and Escherichia coli infections.
Gaspari R; Spinazzola G; Teofili L; Avolio AW; Fiori B; Maresca GM; Spanu T; Nicolotti N; De Pascale G; Antonelli M
Eur J Clin Invest; 2021 Dec; 51(12):e13687. PubMed ID: 34599600
[TBL] [Abstract][Full Text] [Related]
7. Spread of Carbapenem-Resistant Klebsiella pneumoniae in an Intensive Care Unit: A Whole-Genome Sequence-Based Prospective Observational Study.
Wei L; Wu L; Wen H; Feng Y; Zhu S; Liu Y; Tang L; Doughty E; van Schaik W; McNally A; Zong Z
Microbiol Spectr; 2021 Sep; 9(1):e0005821. PubMed ID: 34259540
[TBL] [Abstract][Full Text] [Related]
8. Genetic Diversity, Antimicrobial Resistance Pattern, and Biofilm Formation in
Ghanizadeh A; Najafizade M; Rashki S; Marzhoseyni Z; Motallebi M
Biomed Res Int; 2021; 2021():2347872. PubMed ID: 34957300
[TBL] [Abstract][Full Text] [Related]
9. Chlorhexidine washing in intensive care does not reduce bloodstream infections, blood culture contamination and drug-resistant microorganism acquisition: an interrupted time series analysis.
Kengen R; Thoonen E; Daveson K; Loong B; Rodgers H; Beckingham W; Kennedy K; Suwandarathne R; van Haren F
Crit Care Resusc; 2018 Sep; 20(3):231-240. PubMed ID: 30153786
[TBL] [Abstract][Full Text] [Related]
10. Multicenter study on the prevalence of colonization due to carbapenem-resistant
Fasciana T; Antonelli A; Bianco G; Lombardo D; Codda G; Roscetto E; Perez M; Lipari D; Arrigo I; Galia E; Tricoli MR; Calvo M; Niccolai C; Morecchiato F; Errico G; Stefani S; Cavallo R; Marchese A; Catania MR; Ambretti S; Rossolini GM; Pantosti A; Palamara AT; Sabbatucci M; Serra N; Giammanco A
Front Public Health; 2023; 11():1270924. PubMed ID: 38186699
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of bacterial agents isolated from endotracheal aspirate cultures of Covid-19 general intensive care patients and their antibiotic resistance profiles compared to pre-pandemic conditions.
Bahçe YG; Acer Ö; Özüdoğru O
Microb Pathog; 2022 Mar; 164():105409. PubMed ID: 35041973
[TBL] [Abstract][Full Text] [Related]
12. The challenge of preventing and containing outbreaks of multidrug-resistant organisms and Candida auris during the coronavirus disease 2019 pandemic: report of a carbapenem-resistant Acinetobacter baumannii outbreak and a systematic review of the literature.
Thoma R; Seneghini M; Seiffert SN; Vuichard Gysin D; Scanferla G; Haller S; Flury D; Boggian K; Kleger GR; Filipovic M; Nolte O; Schlegel M; Kohler P
Antimicrob Resist Infect Control; 2022 Jan; 11(1):12. PubMed ID: 35063032
[TBL] [Abstract][Full Text] [Related]
13. Resistance patterns and outcomes in intensive care unit (ICU)-acquired pneumonia. Validation of European Centre for Disease Prevention and Control (ECDC) and the Centers for Disease Control and Prevention (CDC) classification of multidrug resistant organisms.
Martin-Loeches I; Torres A; Rinaudo M; Terraneo S; de Rosa F; Ramirez P; Diaz E; Fernández-Barat L; Li Bassi GL; Ferrer M
J Infect; 2015 Mar; 70(3):213-22. PubMed ID: 25445887
[TBL] [Abstract][Full Text] [Related]
14. Relationship between immunosuppression and intensive care unit-acquired multidrug-resistant bacteria: a case-control study.
Nseir S; Di Pompeo C; Diarra M; Brisson H; Tissier S; Boulo M; Durocher A
Crit Care Med; 2007 May; 35(5):1318-23. PubMed ID: 17414081
[TBL] [Abstract][Full Text] [Related]
15. [Is there a relationship between rectal colonization and nosocomial infection of patients in intensive care unit?].
Yeşilbağ Z; Çağatay AA; Karadeniz A; Başaran S; Orhun G; Ergin Özcan P; Özsüt H; Eraksoy H
Mikrobiyol Bul; 2015 Jul; 49(3):327-39. PubMed ID: 26313275
[TBL] [Abstract][Full Text] [Related]
16. A Comparative Study on Bacterial Co-Infections and Prevalence of Multidrug Resistant Organisms among Patients in COVID and Non-COVID Intensive Care Units.
Sathyakamala R; Peace AR; Shanmugam P
J Prev Med Hyg; 2022 Mar; 63(1):E19-E26. PubMed ID: 35647371
[TBL] [Abstract][Full Text] [Related]
17. Phenotypic and molecular characterization of Acinetobacter baumannii isolates causing lower respiratory infections among ICU patients.
Jain M; Sharma A; Sen MK; Rani V; Gaind R; Suri JC
Microb Pathog; 2019 Mar; 128():75-81. PubMed ID: 30562602
[TBL] [Abstract][Full Text] [Related]
18. Incidence of bloodstream infections due to multidrug-resistant pathogens in ordinary wards and intensive care units before and during the COVID-19 pandemic: a real-life, retrospective observational study.
Segala FV; Pafundi PC; Masciocchi C; Fiori B; Taddei E; Antenucci L; De Angelis G; Guerriero S; Pastorino R; Damiani A; Posteraro B; Sanguinetti M; De Pascale G; Fantoni M; Murri R
Infection; 2023 Aug; 51(4):1061-1069. PubMed ID: 36867310
[TBL] [Abstract][Full Text] [Related]
19. Multidrug-Resistant Infections and Outcome of Critically Ill Patients with Coronavirus Disease 2019: A Single Center Experience.
Karruli A; Boccia F; Gagliardi M; Patauner F; Ursi MP; Sommese P; De Rosa R; Murino P; Ruocco G; Corcione A; Andini R; Zampino R; Durante-Mangoni E
Microb Drug Resist; 2021 Sep; 27(9):1167-1175. PubMed ID: 33600262
[No Abstract] [Full Text] [Related]
20. Stopping Hospital Infections With Environmental Services (SHINE): A Cluster-randomized Trial of Intensive Monitoring Methods for Terminal Room Cleaning on Rates of Multidrug-resistant Organisms in the Intensive Care Unit.
Ziegler MJ; Babcock HH; Welbel SF; Warren DK; Trick WE; Tolomeo P; Omorogbe J; Garcia D; Habrock-Bach T; Donceras O; Gaynes S; Cressman L; Burnham JP; Bilker W; Reddy SC; Pegues D; Lautenbach E; Kelly BJ; Fuchs B; Martin ND; Han JH
Clin Infect Dis; 2022 Sep; 75(7):1217-1223. PubMed ID: 35100614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
